Walk Back Those Walking Claims, FDA Tells Acorda And Valeant
In separate “notice of violation” letters sent the same day to Acorda and Valeant, FDA stresses the limits of what companies can do with patient testimonials in web videos.
In separate “notice of violation” letters sent the same day to Acorda and Valeant, FDA stresses the limits of what companies can do with patient testimonials in web videos.